Literature DB >> 9208258

Treatment of patent foramen ovale and stroke: to close or not to close, that is not yet the question.

R L Sacco, M R Di Tullio, S Homma.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9208258     DOI： 10.1159/000117443

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  4 in total

1.  Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow.

Authors:  Mary F Lopez; David A Sarracino; Maryann Vogelsang; Jennifer N Sutton; Michael Athanas; Bryan Krastins; Alejandra Garces; Amol Prakash; Scott Peterman; Zareh Demirjian; Ignacio Inglessis-Azuaje; Kathleen Feeney; Mikaela Elia; David McMullin; G William Dec; Igor Palacios; Eng H Lo; Ferdinand Buonanno; MingMing Ning
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

2.  [Detection of patent foramen ovale. Transesophageal echocardiography and transcranial Doppler sonography with ultrasound contrast media are "supplementary, not competing, diagnostic methods"].

Authors:  J G Heckmann; W Niedermeier; M Brandt-Pohlmann; M J Hilz; M Hecht; B Neundörfer
Journal:  Med Klin (Munich)       Date:  1999-07-15

Review 3.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 4.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.